Medpace Holdings, Inc. (NASDAQ:MEDP) Receives $376.30 Average Target Price from Analysts
Medpace Holdings, Inc. (NASDAQ:MEDP – Get Free Report) has received an average rating of “Hold” from the thirteen research firms that are covering the firm, MarketBeat.com reports. Eight equities research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12 month price objective […]
More Stories
Bristol Myers Squibb Company (NYSE:BMY) Shares Sold by Spire Wealth Management
Spire Wealth Management reduced its position in shares of Bristol Myers Squibb Company (NYSE:BMY – Free Report) by 1.6% in...
Golden State Wealth Management LLC Acquires 974 Shares of Zoetis Inc. (NYSE:ZTS)
Golden State Wealth Management LLC increased its holdings in Zoetis Inc. (NYSE:ZTS – Free Report) by 90.6% in the first...
Zoetis Inc. (NYSE:ZTS) Shares Sold by Bessemer Group Inc.
Bessemer Group Inc. decreased its stake in shares of Zoetis Inc. (NYSE:ZTS – Free Report) by 42.6% during the 1st...
Golden State Wealth Management LLC Acquires 4,508 Shares of CSX Corporation (NASDAQ:CSX)
Golden State Wealth Management LLC increased its holdings in shares of CSX Corporation (NASDAQ:CSX – Free Report) by 123.1% in...
Golden State Wealth Management LLC Grows Stake in Meta Platforms, Inc. (NASDAQ:META)
Golden State Wealth Management LLC grew its position in Meta Platforms, Inc. (NASDAQ:META – Free Report) by 151.1% during the...
Golden State Wealth Management LLC Has $319,000 Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)
Golden State Wealth Management LLC increased its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 623.1% during the...